RecruitingNot ApplicableNCT04442646

Role of "Asthma School" in Disease Management


Sponsor

Istituti Clinici Scientifici Maugeri SpA

Enrollment

92 participants

Start Date

Apr 1, 2019

Study Type

INTERVENTIONAL

Conditions

Summary

According to the definition provided by the GINA guidelines, asthma is characterized by a variable and reversible limitation of expiratory airflow and by the following symptoms: wheezing, dyspnoea, thoracic constriction and/or cough. The type and the severity of airflow limitation can vary over time (1) depending on external agents, such as physical exercise, polluting agents, climate changes and viral infections. The therapy is mainly based on the use of inhaled corticosteroids and bronchodilators. Patients affected by severe asthma (\~ 10% of total prevalence of asthma and at high risk of exacerbations and/or hospitalization) may not control their symptoms, even if exposed to maximal doses of inhalation therapy.The behavioural sciences can potentially help to find the psychological factors behind scarce adherence and to develop strategies with the aim of improving the interactive processes between patients, medical doctors and health care professionals


Eligibility

Min Age: 18 YearsMax Age: 85 Years

Inclusion Criteria2

  • Asthma diagnosis according to GINA / ATS guidelines.
  • Age ≥18 years

Exclusion Criteria1

  • •cognitive impairment

Interventions

BEHAVIORALmultidisciplinary lessons

the multidisciplinary lessons will be conducted by study staff, formed by pneumologist, nurse, biologist and respiratory therapist once a week within 1 month after randomization. Study staff will deal with the following topics: asthma physiopathology, recognition of asthma symptoms and exacerbation, educational interventions on therapy and device, nutritional counselling if necessary. Patients will receive a paper diary for symptoms and an expiratory pick flow meter (PFM) to be done twice a day


Locations(1)

Istituti Clinici Maugeri Pneumologia

Tradate, Lombardy, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04442646


Related Trials